Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications

A technology of masarginic acid and co-crystals, applied in the field of masarginic acid co-crystals, its preparation, purification and its application in the preparation of drugs for the treatment of diabetic complications, which can solve problems such as male sexual dysfunction

Active Publication Date: 2012-07-25
南京瑞因大健健康科技有限公司
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0022] The above inventions have not yet involved the use of rhein or rhein compound compounds to treat diabetic complications, including the treatment of diabetic cardiomyopathy; diabetic macroangiopathy; male sexual dysfunction

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications
  • Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications
  • Rhein-arginine eutectic compound, and preparation method, purification method and application thereof in preparation of medicines for treating diabetic complications

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0197] Example 1, take 2.0 g of rhein and 1.23 g of arginine, mix them, add 200 mL of water, heat to 90° C., keep warm for 1 hour, and filter while hot. Add ethanol to the filtrate so that the alcohol content is 80%. Under a water bath at 60°C, recover the solvent under reduced pressure until the volume is reduced by half, cool down to 4-10°C, let stand, crystallize, filter, and dry to obtain a large Type I crystallization of succinic acid.

Embodiment 2

[0198] Example 2, take 2.0 g of rhein and 1.23 g of arginine, mix them, add 200 mL of water, heat to 80° C., keep warm for 1.5 h, and filter while hot. Add ethanol to the filtrate to make the alcohol content 60%, recover the ethanol solvent under reduced pressure in a water bath at 50°C until the volume is reduced by half, cool down to 4-10°C, let stand, crystallize, filter, and dry to obtain the Type I crystallization of succinic acid.

Embodiment 3

[0199] Example 3, take 2.0 g of rhein and 1.23 g of arginine, mix them, add 250 mL of water, heat to 75° C., keep warm for 2 hours, and filter while hot. Add ethanol to the filtrate to make the alcohol content 40%, recover the solvent under reduced pressure in a water bath at 65°C until the volume is reduced by half, cool down to 20-30°C, keep it warm for 4 hours, then cool down to 4-10°C, Stand still, crystallize, filter, and dry to obtain type I crystals of macrospermic acid. Take an appropriate amount of rhein type I crystal product, add water, heat to dissolve, add dilute hydrochloric acid to adjust the pH to 2, collect the precipitate, wash the precipitate with water until neutral, and dry to obtain the purified rhein product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
melting pointaaaaaaaaaa
Login to View More

Abstract

The invention relates to a rhein-arginine eutectic compound, and a preparation method, a purification method and application thereof in preparation of medicines for treating diabetic complications. The rhein-arginine eutectic compound is an eutectic substance formed by rhein and L-arginine, the mol ratio of the active medicine component of the rhein to the L-arginine is 1:1, and the X-ray diffractogram of the eutectic powder has the characteristic peaks of 9.22 degrees, 10.34 degrees, 12.28 degrees, 26.05 degrees, 26.58 degrees and 27.57 degrees 2theta. The medicines for treating diabetic complications are medicines for treating diabetic cardiopathy, medicines for treating diabetic macroangiopathy, medicines for treating diabetic nephropathy, medicines for treating diabetic orchiopathy, medicines for treating complicated male sexual dysfunction of diabetes, or medicines for treating diabetic impotence. The invention can increase the solubility and dissolution of the medicines, enhance the purity and stability of the rhein-arginine eutectic compound, reduce the impurity content and hygroscopicity, enhance the bioavailability and improve the release characteristic.

Description

technical field [0001] The present invention relates to a compound of rhein arginine, which uses supramolecular chemical co-crystal technology to prepare co-crystal-arginine (Argirein), that is, the active pharmaceutical ingredient rhein (rhein) and co-crystal A co-crystal (a kind of complex) formed by crystal former L-arginine (L-arginine), the present invention also relates to the preparation method of this large spermatic acid co-crystal compound, this large-arginic acid co-crystal compound A purification method with rhein, and the application of the macrospergic acid co-crystal in the preparation of drugs for treating diabetic complications. Background technique [0002] Diabetes and its complications are common and frequently-occurring diseases. The incidence of diabetes remains high, showing a trend of high incidence. The incidence rate in China is higher. Diabetes is mainly type II, which affects the middle-aged and elderly people. It is highly pathogenic and has b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C279/14C07C66/02C07C277/08C07C51/00C07C51/43A61P3/10A61P9/10A61P13/12A61P15/08A61P15/10A61P25/00A61K31/205A61K31/192
Inventor 丛晓东戴德哉戴茵迟宗良
Owner 南京瑞因大健健康科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com